Understanding BIA-ALCL Symptoms: Myths, Risks, and What You Need to Know About Prevention and Treatment

Breast implants have long been a popular option for women seeking breast augmentation or reconstruction. However, in recent years, concerns about Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) have raised questions about the safety of breast implants.

If you’re considering breast augmentation or already have implants, understanding the risks, symptoms, and treatment options for BIA-ALCL is essential. In this blog, we’ll separate myths from facts and provide clear, evidence-based information.

What is BIA-ALCL?

BIA-ALCL (Breast Implant-Associated Anaplastic Large Cell Lymphoma) is a rare form of lymphoma, a type of non-Hodgkin’s lymphoma that affects the immune system. It is not breast cancer but rather a cancer of the lymphatic system.

BIA-ALCL develops in the scar tissue and fluid surrounding a breast implant rather than in the breast tissue itself. It is most commonly associated with implants that have a textured surface rather than smooth implants. BIA-ALCL has not been confirmed to occur with smooth implants, and current evidence suggests that smooth implant options have a lower risk profile for this condition.

What is the difference between Breast Implant Illness (BII) and BIA-ALCL?

Breast Implant Illness (BII) and Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) are two distinct conditions related to breast implants, but they differ significantly in their nature, symptoms, diagnosis, and treatment.

Breast Implant Illness (BII) refers to a broad spectrum of systemic symptoms that some breast implant patients experience. These breast implant illness symptoms can include chronic fatigue, joint and muscle pain, memory loss, brain fog, anxiety, depression, and other nonspecific complaints. BII is not yet recognised as an official medical diagnosis, and its exact cause remains unclear. Many healthcare providers believe breast implant illness may be related to an autoimmune or inflammatory response triggered by the breast implants or their surrounding tissue capsule. Getting breast implant illness diagnosed involves ruling out other diseases and conditions with similar symptoms, often requiring comprehensive diagnostic tests and treatment planning tailored to the individual. While some patients report improvement of breast implant illness symptoms after breast implant removal, the response varies, and more research is needed to understand this condition fully.

On the other hand, BIA-ALCL is a rare type of immune system cancer classified as a T-cell lymphoma. It specifically develops in the tissue capsule and fluid surrounding textured breast implants, usually many years after implant surgery. BIA-ALCL presents with localized symptoms such as swelling due to fluid accumulation, lumps near the implant, breast pain, skin rash, or changes in breast shape. Unlike breast implant illness, BIA-ALCL has defined diagnostic criteria, including imaging tests, fluid analysis, and biopsy, making it an official medical diagnosis. Treatment typically involves surgical removal of the implant and the entire capsule (en bloc capsulectomy), sometimes accompanied by additional therapies such as radiation therapy or chemotherapy in advanced cases.

Understanding the differences between breast implant illness and BIA-ALCL is crucial for breast implant patients and healthcare providers. While both conditions may share some overlapping symptoms, such as breast pain and systemic complaints, BIA-ALCL is a distinct malignancy requiring prompt diagnosis and treatment, whereas breast implant illness remains a complex syndrome with ongoing research to establish its underlying mechanisms and optimal management strategies.

How Rare is BIA-ALCL?

According to the Therapeutic Goods Administration (TGA) in Australia, the estimated risk of developing BIA-ALCL varies depending on the type of textured implant used:

• Implants with a rougher texture (macro-textured) have a higher risk.
• The risk is significantly lower for micro-textured or smooth implants.

BIA-ALCL has been reported in patients with both silicone and saline implants, indicating that the risk is associated with the textured surface of the implant rather than the internal fill material.

The current estimated lifetime risk of developing BIA-ALCL in Australia is approximately 1 in 2,500 to 1 in 85,000 for women with textured implants.

While the risk is low, it is important to be informed and vigilant.

How is BIA-ALCL diagnosed?

Diagnosing BIA-ALCL involves a combination of clinical evaluation, imaging studies, and laboratory tests to accurately identify the presence of this rare lymphoma. The process typically begins when a patient presents with symptoms such as swelling, pain, or a lump near the breast implant. A thorough physical examination by a healthcare provider or plastic surgeon is essential to assess any abnormalities in the breast or surrounding areas.

Imaging tests play a critical role in the diagnosis. Ultrasound is often the first imaging modality used to detect fluid accumulation (seroma) or masses around the implant. Magnetic Resonance Imaging (MRI) can provide more detailed images of the breast tissue, implant integrity, and surrounding capsule, helping to identify suspicious areas that may not be visible on ultrasound.

If fluid is detected around the implant, a fine-needle aspiration (FNA) biopsy is performed to collect a sample of the fluid. This sample is sent to a pathology laboratory where it undergoes cytological examination to detect the presence of malignant cells characteristic of BIA-ALCL. Immunohistochemistry tests are used to identify specific markers such as CD30, which is typically positive in BIA-ALCL cells, confirming the diagnosis.

In some cases, a biopsy of the surrounding scar tissue capsule may be necessary to evaluate the extent of disease involvement. Advanced imaging techniques, including Positron Emission Tomography (PET) scans, may be used to assess whether the lymphoma has spread beyond the breast area to lymph nodes or other parts of the body.

Because BIA-ALCL symptoms can resemble those of other conditions, differential diagnosis is important to rule out infections, implant rupture, or other malignancies. Early and accurate diagnosis is vital to guide appropriate treatment planning and improve patient outcomes.

Patients diagnosed with BIA-ALCL should be managed by a multidisciplinary team including plastic surgeons, oncologists, and pathologists to ensure comprehensive care. Prompt surgical intervention, often involving en bloc capsulectomy and implant removal, is the cornerstone of treatment, with additional therapies considered based on disease stage.

Regular follow-up and monitoring after diagnosis and treatment are essential to detect any recurrence and to support the patient’s recovery and long-term health.

BIA-ALCL Symptoms

Recognizing the symptoms of BIA-ALCL is crucial, as this condition usually develops years after breast implant surgery, with most cases occurring between 3 to 14 years post-surgery.

The most common BIA-ALCL symptoms include:

• Swelling in the breast due to fluid buildup (seroma)
• Pain or discomfort in one or both breasts
• A lump near the implant or in the surrounding tissue
• Hardening of the breast or changes in its shape
• Skin rash or redness over the breast

If you experience any of these common symptoms, it is essential to seek medical advice. Early detection leads to better treatment outcomes.

Understanding the Link Between Implants and BIA-ALCL

Research suggests that BIA-ALCL is linked to chronic inflammation caused by certain textured implants. Over time, inflammation may lead to abnormal immune responses, potentially triggering lymphoma in a small number of cases.

In 2019, the TGA recalled and banned certain textured implants in Australia due to their association with BIA-ALCL. Breast implant manufacturers were required to comply with these regulatory actions and provide updated safety information to patients and surgeons. Since then, plastic surgeons, including Dr Rohit Kumar, have prioritised patient safety by offering alternative implant options and discussing individual risk factors.

How to Reduce the Risk of BIA-ALCL?

While there is no guaranteed way to prevent BIA-ALCL, certain steps can reduce the risk. Overall, breast augmentation with modern techniques and careful monitoring carries a low risk of serious complications such as BIA-ALCL.

1. Choosing the Right Implant

• Smooth implants have not been linked to BIA-ALCL and are considered a safer alternative.
• Micro-textured implants have a lower risk than macro-textured implants.

Both silicone and saline implants are available with smooth or textured surfaces. The risk of BIA-ALCL is associated with the textured surface of the implant, not whether the implant is filled with silicone or saline.

• Discussing implant options with an experienced plastic surgeon like Dr Kumar ensures you make an informed choice.

2. Proper Surgical Techniques

• Surgeons who follow best practices in sterile surgical techniques and proper implant placement can reduce long-term inflammation.
• Dr Kumar uses meticulous surgical methods to optimise safety.

3. Regular Breast Health Checks

• Routine follow-ups with your plastic surgeon and self-examinations help detect any unusual changes early. A physical exam by your surgeon is a critical step in assessing any changes or symptoms.
• Ultrasound or MRI scans may be recommended if any concerns arise. While a physical examination is important, some complications such as silent implant ruptures may not be detectable without specialized imaging. Magnetic resonance imaging (MRI) is the most effective imaging test for detecting silent ruptures in silicone implants.

4. Understanding When to Seek Medical Advice

• If you notice changes in your breasts, don’t ignore them. Seek medical advice as early intervention improves outcomes.

Myths vs. Facts About BIA-ALCL

Myth 1: All breast implants cause cancer.

Fact: BIA-ALCL is extremely rare and is primarily associated with textured breast implants, not smooth implants. The majority of women with implants never develop this condition.

Myth 2: BIA-ALCL develops immediately after surgery.

Fact: BIA-ALCL typically occurs several years after implantation, often between 3 and 14 years post-surgery.

Myth 3: If I have textured implants, I should get them removed immediately.

Fact: If you have no symptoms, having your implants removed is not recommended. The risks of surgery may outweigh potential benefits, and routine removal of implants is not advised for asymptomatic individuals. However, if you experience swelling or lumps, consult a specialist for evaluation.

Myth 4: BIA-ALCL is untreatable.

Fact: BIA-ALCL is highly treatable when diagnosed early. In most cases, removing the implant and the surrounding capsule is sufficient. For confirmed BIA-ALCL cases, surgical removal of the implant and capsule is the standard treatment. Advanced cases may require additional treatments.

Treatment Options for BIA-ALCL

Early diagnosis is key to successful treatment. If BIA-ALCL is suspected, your doctor will conduct diagnostic tests, including imaging tests and fluid analysis, to confirm the diagnosis. These may include:

• Ultrasound or MRI scans to assess fluid buildup.
• Fine-needle aspiration biopsy to test the fluid for cancer cells.
• Imaging tests such as PET/CT scans may be used to monitor for recurrence after surgical removal.

Surgical Treatment

• En Bloc Capsulectomy – Removal of the implant and the surrounding capsule is the standard treatment.
• Lymph Node Assessment – In rare cases where the cancer has spread, further treatment may be needed. In advanced cases, BIA-ALCL may extend to the chest wall, requiring more extensive surgical intervention and multidisciplinary management.

Additional Treatments

• Chemotherapy or targeted therapies may be required in very advanced cases, but most cases do not progress to this stage.

What If I Am Concerned About My Implants?

If you have breast implants and are concerned about BIA-ALCL, here’s what you can do:

• Monitor for Symptoms: Pay attention to any swelling, lumps, or pain. Breast implant patients should be aware of both localized and systemic symptoms, including joint pain, muscle pain, chronic fatigue, memory loss, and brain fog.
• Schedule Regular Check-Ups: A consultation with Dr Rohit Kumar can provide reassurance and guidance.
• Know Your Implant Type: If unsure, ask your surgeon for details about your implants.

Many breast implant patients have concerns about a range of symptoms. Breast implant illness (BII) is a term used to describe a collection of systemic symptoms that some patients attribute to their implants, and breast implant illness symptoms can overlap with those of autoimmune conditions and other diseases. BII symptoms may include joint and muscle pain, chronic fatigue, memory loss, brain fog, and breast pain. Diagnostic tests may be needed to rule out other diseases, such as autoimmune conditions, when evaluating BII symptoms. Social media groups can be a source of support and information for patients experiencing breast implant illness symptoms, but information should be evaluated critically.

For women considering implant removal, Dr Kumar provides individualised assessments to determine the best course of action based on your health and personal goals. Breast implant removal is a surgical procedure that may involve removing the implant alone or with the surrounding capsule, and patients should discuss the best approach with their surgeon. Some patients choose to have their breast implants removed due to complications such as capsular contracture, implant rupture, or persistent breast pain. Changes in breast sensation, breast skin, or the presence of tissue expanders may also influence the decision for breast reconstruction after implant removal. In women undergoing revision surgery or implant removal, volume can be preserved or adjusted using fat transfer, which may provide a natural option without introducing an implant.

Final Thoughts

BIA-ALCL is rare but important to understand. While textured implants carry a small risk, the majority of women with implants never experience this condition.

At his Sydney practice in Penrith and Westmead, Dr Rohit Kumar prioritises patient safety, providing evidence-based guidance on breast implants and associated risks. If you have concerns or want to discuss your options, booking a consultation can help you make an informed decision.

For expert advice on breast implants and your health, contact Dr Rohit Kumar’s clinic today.